Viemed Healthcare, Inc. reported a significant increase in financial performance for the first quarter of 2026, with total revenue reaching $75.4 million, a 27.5% increase from $59.1 million in the same period of 2025. The company's gross profit also rose to $42.8 million, reflecting a gross profit margin improvement to 56.8% from 56.3% year-over-year. Net income for the quarter was $2.7 million, slightly up from $2.7 million in the previous year, although net income attributable to the company decreased marginally to $2.6 million from $2.6 million. The company attributed the revenue growth to increased patient volumes and the expansion of its product offerings, particularly in the home medical equipment sector.
In terms of operational metrics, Viemed's patient base expanded, with notable increases in ventilator rentals and other home medical equipment rentals. Ventilator rental revenue grew by 10% to $35.4 million, while revenue from other home medical equipment rentals surged by 25% to $16.2 million. Equipment and supply sales saw a remarkable increase of 132.6%, totaling $17.5 million, largely driven by the inclusion of maternal health products from the acquisition of Lehan Drugs, Inc. in July 2025. The company’s workforce also expanded, with the employee count rising to 1,387, a 14% increase from the previous year.
Viemed's balance sheet showed total assets of $197.4 million as of March 31, 2026, a slight decrease from $199.2 million at the end of 2025. Current assets increased to $49.8 million, primarily due to higher accounts receivable, which rose to $231.2 million. The company’s total liabilities decreased to $51.6 million, down from $55.6 million, reflecting a reduction in long-term debt and accrued liabilities. The company’s cash and cash equivalents stood at $9.8 million, down from $13.5 million at the end of the previous year.
Looking ahead, Viemed plans to continue its growth trajectory by expanding its service areas and enhancing its workforce of licensed clinical practitioners. The company aims to leverage its technology-enabled home-based clinical care model to meet the increasing demand for home medical equipment and services. Viemed's management remains optimistic about the ongoing trend of transitioning care from hospitals to home settings, which aligns with its strategic objectives. The company is also focused on managing cost pressures and maintaining operational efficiency as it navigates the evolving healthcare landscape.
About VIEMED HEALTHCARE, INC.
Viemed Healthcare, Inc. provides home medical equipment and respiratory healthcare services across the U.S., focusing on in-home treatment for respiratory diseases. Its offerings include ventilators, oxygen therapy, sleep testing, and staffing services. Serving primarily Medicare and private insurers, Viemed emphasizes cost-effective, high-quality care, leveraging clinical expertise and technology to support patient health while navigating complex regulatory and reimbursement environments.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.